Psagot Investment House »

Keros Therapeutics shares owned by Psagot Investment House

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Psagot Investment House from 13F filings

Historical chart of Psagot Investment House investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Psagot Investment House consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Psagot Investment House

Quarter filed Position value Share count Share price at filing
2021-09-30 $110k 2.8k 39.68
2021-06-30 $2.4M 57k 42.48

More positions owned by Psagot Investment House

Microsoft Corporation (MSFT)
Apple (AAPL)
Facebook Cl A (META)
Alphabet Cap Stk Cl A Added (GOOGL)
Mastercard Cl A (MA)
Pypl Us Com Added (PYPL)
JPMorgan Chase & Co. (JPM)
salesforce (CRM)
Goog Us Cap Stk Cl C Added (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Lululemon Athletica (LULU)
Kraneshares Tr Csi Chi Internet (KWEB)
SPDR Tr Unit (SPY)
Comcast A Cl A (CMCSA)
Procter & Gamble Company (PG)

View all positions for Psagot Investment House

Top funds holding Keros Therapeutics

Vanguard Group
OrbiMed Advisors
Braidwell
Darwin Global Management
T. Rowe Price Associates
Candriam Luxembourg S.C.A.
Citadel Advisors
Franklin Resources
ADAR1 Capital Management
Eventide Asset Management
Millennium Management
Deutsche Bank Aktiengesellschaft
Opaleye Management
Blue Owl Capital Holdings
Nantahala Capital Management

View all funds holding Keros Therapeutics